Updated Jul 16, 2026
Aranda Richard is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Richard Aranda is the Chief Medical Officer at Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for immunology, inflammation, and oncology. He has been involved in the company's efforts to advance its pipeline products.
| Role | Chief Medical Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-01 | GOSS | Gossamer Bio, Inc. | A — Grant or award | 162.5K | $0.00 |
Richard Aranda is the Chief Medical Officer at Gossamer Bio, Inc., a clinical-stage biopharmaceutical company focused on developing therapeutics for immunology, inflammation, and oncology. He has been involved in the company's efforts to advance its pipeline products.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Aranda Richard profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.